Prognostic Tools in Patients With Advanced Cancer: A Systematic Review

被引:138
|
作者
Simmons, Claribel P. L. [1 ]
McMillan, Donald C. [2 ]
McWilliams, Kerry [1 ]
Sande, Tonje A. [1 ]
Fearon, Kenneth C. [1 ]
Tuck, Sharon [1 ]
Fallon, Marie T. [1 ]
Laird, Barry J. [1 ,3 ]
机构
[1] Univ Edinburgh, Edinburgh, Midlothian, Scotland
[2] Univ Glasgow, Dept Surg Sci, Glasgow, Lanark, Scotland
[3] Norwegian Univ Sci & Technol, European Palliat Care Res Ctr, Trondheim, Norway
关键词
Prognostic tools; cancer; review; PALLIATIVE PERFORMANCE SCALE; SURVIVAL PREDICTION; LIFE EXPECTANCY; SCORE; INDEX; CARE; VALIDATION; ACCURACY; TIME; RECOMMENDATIONS;
D O I
10.1016/j.jpainsymman.2016.12.330
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Purpose. In 2005, the European Association for Palliative Care made recommendations for prognostic markers in advanced cancer. Since then, prognostic tools have been developed, evolved, and validated. The aim of this systematic review was to examine the progress in the development and validation of prognostic tools. Methods. Medline, Embase Classic and Embase were searched. Eligible studies met the following criteria: patients with incurable cancer, >18 years, original studies, population n >= 100, and published after 2003. Descriptive and quantitative statistical analyses were performed. Results. Forty-nine studies were eligible, assessing seven prognostic tools across different care settings, primary cancer types, and statistically assessed survival prediction. The Palliative Performance Scale was the most studied (n = 21,082), comprising six parameters (six subjective), was externally validated, and predicted survival. The Palliative Prognostic Score composed of six parameters (four subjective and two objective), the Palliative Prognostic Index composed of nine parameters ( nine subjective), and the Glasgow Prognostic Score composed of two parameters ( two objective) and were all externally validated in more than 2000 patients with advanced cancer and predicted survival. Conclusion. Various prognostic tools have been validated but vary in their complexity, subjectivity, and therefore clinical utility. The Glasgow Prognostic Score would seem the most favorable as it uses only two parameters ( both objective) and has prognostic value complementary to the gold standard measure, which is performance status. Further studies comparing all proved prognostic markers in a single cohort of patients with advanced cancer are needed to determine the optimal prognostic tool. J Pain Symptom Manage. (C) 2016 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:962 / +
页数:19
相关论文
共 50 条
  • [21] Prognostic factors in patients with oligometastatic breast cancer - A systematic review
    van Ommen-Nijhof, Annemiek
    Steenbruggen, Tessa G.
    Schats, Winnie
    Wiersma, Terry
    Horlings, Hugo M.
    Mann, Ritse
    Koppert, Linetta
    van Werkhoven, Erik
    Sonke, Gabe S.
    Jager, Agnes
    CANCER TREATMENT REVIEWS, 2020, 91
  • [22] The prognostic value of sarcopenia in patients with prostate cancer: a systematic review
    Jahrreiss, Victoria
    Laukhtina, Ekaterina
    D'Andrea, David
    Shariat, Shahrokh F.
    CURRENT OPINION IN UROLOGY, 2021, 31 (04) : 315 - 323
  • [23] Systematic Review of Prognostic Gene Signature in Gastric Cancer Patients
    Xie, Longxiang
    Cai, Linghao
    Wang, Fei
    Zhang, Lu
    Wang, Qiang
    Guo, Xiangqian
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2020, 8
  • [24] Diagnostic and prognostic factors in patients with prostate cancer: a systematic review
    Beyer, Katharina
    Moris, Lisa
    Lardas, Michael
    Haire, Anna
    Barletta, Francesco
    Scuderi, Simone
    Molnar, Megan
    Herrera, Ronald
    Rauf, Abdul
    Campi, Riccardo
    Greco, Isabella
    Shiranov, Kirill
    Dabestani, Saeed
    van den Broeck, Thomas
    Arun, Sujenthiran
    Gacci, Mauro
    Gandaglia, Giorgio
    Omar, Muhammad Imran
    MacLennan, Steven
    Roobol, Monique J.
    Farahmand, Bahman
    Vradi, Eleni
    Devecseri, Zsuzsanna
    Asiimwe, Alex
    Zong, Jihong
    Maclennan, Sara J.
    Collette, Laurence
    NDow, James
    Briganti, Alberto
    Bjartell, Anders
    Van Hemelrijck, Mieke
    BMJ OPEN, 2022, 12 (04):
  • [25] Factors associated with prognostic awareness in patients with cancer: A systematic review
    Vlckova, Karolina
    Tuckova, Anna
    Polakova, Kristyna
    Loucka, Martin
    PSYCHO-ONCOLOGY, 2020, 29 (06) : 990 - 1003
  • [26] Oral symptom assessment tools in patients with advanced cancer: a scoping review
    Cleary, Niamh
    Mulkerrin, Olivia Munnelly
    Davies, Andrew
    SUPPORTIVE CARE IN CANCER, 2022, 30 (09) : 7481 - 7490
  • [27] Oral symptom assessment tools in patients with advanced cancer: a scoping review
    Niamh Cleary
    Olivia Munnelly Mulkerrin
    Andrew Davies
    Supportive Care in Cancer, 2022, 30 : 7481 - 7490
  • [28] Evaluation of prognostic tools in locally advanced rectal cancer patients treated with neoadjuvant chemoradiotherapy
    Gomez Mugarza, P.
    Polo, E.
    Lopez Roldan, B.
    Barriendos Sanz, S.
    Monreal Cepero, M.
    Campos Ramirez, S.
    Mocha Campillo, F.
    Trincado Cobos, P.
    Comin, A.
    Ponce, J.
    Navarro Aznar, V.
    Gurruchaga Sotes, I.
    Nuno Alves, A.
    Felices Lobera, M.
    Alonso Orduna, V.
    ANNALS OF ONCOLOGY, 2022, 33 : S277 - S277
  • [29] Psychosocial interventions for patients with advanced cancer - a systematic review of the literature
    Uitterhoeve, RJ
    Vernooy, M
    Litjens, M
    Potting, K
    Bensing, J
    De Mulder, P
    van Achterberg, T
    BRITISH JOURNAL OF CANCER, 2004, 91 (06) : 1050 - 1062
  • [30] Side effects of corticosteroids in patients with advanced cancer: a systematic review
    Yutaka Hatano
    Hiromichi Matsuoka
    Lawrence Lam
    David C. Currow
    Supportive Care in Cancer, 2018, 26 : 3979 - 3983